Key Research Properties: Small molecule NNMT (nicotinamide N-methyltransferase) inhibitor Modulates NAD+ metabolism and methylation capacity Studied in context of energy expenditure and metabolic regulation NNMT is upregulated in obesity
However, practical protocol design becomes significantly more complex with multi-compound stacks: you must isolate each compounds contribution, monitor for cumulative metabolic stress, and ensure endpoint measurements can differentiate between GH-mediated effects (lipolysis, lean mass changes) and AMPK-mediated effects (insulin sensitivity, fat oxidation)
Side Effects AOD-9604 has a well-documented safety profile, with clinical trials involving over 900 participants showing good tolerability
Safety, Regulatory Status, and Contraindications: AOD-9604 is not FDA-approved and has not completed large-scale human efficacy trials
Reconstitute with a suitable sterile solvent
Her consultative approach discussing pros and cons allows you the time to make an informed decision